Del VillanoB.C., BrennanS., BrockP.. Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9.Clin Chem1983; 29: 549.
3.
BaroneD., OnettoH., ConioM.. CA 19-9 assay in patients with extrahepatic cholestatic jaundice.Int J Biol Markers,1988: 3, 2: 95–100.
4.
SakamotoK., HagaY., YoshimuraR.. Comparative effectiveness of the tumour diagnostics, CA 19.9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system.Gut1987; 28: 323–9.
5.
LamiquizA., LoizateA., DominguezM.J.. Tumor markers in biliopancreatic surgery; round table contribution: carcinoma of the pancreas.X° World Congress of C.I.C.D. Copenhagen (Denmark), Aug-Sept. 1988.
6.
JalankoH., KuuselaP., RobertsP.. Comparison of a new tumour marker, CA 19.9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.J Clin Pathol1984; 37: 218–22.
